NIAID Site Search

The NIAID 17th Annual Fellows Workshop occurred on Friday, December 1, 2023, honoring the exceptional contributions of NIAID predoctoral students, postdoctoral fellows, and clinical fellows. The event showcased fifty-five engaging presentations by fellows, along with insightful remarks from the NIAID Mentor of the Year, Cathryn Haigh, Ph.D., and NIAID's esteemed Clinical Director, H. Clifford Lane, M.D.

Published: December 6, 2023

NIAID postbac Hailey Johnson will represent NIAID at the 2023 NIH Three-minute Talk (TmT) Competition on June 22, 2023. She received the highest marks during NIAID's TmT competition last month for her talk titled, “Identification of Brugia malayi microRNAs Involved in Wolbachia-Host Symbiosis.” The NIH Three-minute Talk Competition occurs annually as part of an effort to improve efficient scientific communication while also showcasing the amazing research carried out by fellows across the NIH.

Published: June 5, 2023

NIAID fellows now have two new representatives to the NIH Fellows Committee, better known as FelCom. Read on to learn more about NIAID’s new FelCom reps, Vaccine Research Center postdoc Sila Ataca and Rocky Mountain Laboratories postdoc Arthur Wickenhagen, Ph.D., and the experiences that led them to their new roles.

Published: July 3, 2023

With the 2023 NIAID Three-minute Talk (TmT) Competition and NIH Postbac Poster Day just around the corner, now is a great time to examine your skills as a presenter and strengthen any areas that need improvement. Check out these strategies for designing great presentations that are memorable and engaging.

Published: April 3, 2023

The purpose of the study is to characterize the immune responses during and after SARS-CoV-2 infection and determine if there is any relationship to clinical course and outcome.

COVID-19

Last Reviewed: March 6, 2024

NIAID postbac Kimberly Manalang received the top score for her talk at the 2024 NIAID TmT Competition last month. She will represent the institute in the NIH-wide TmT Competition on June 27. Learn about her experience participating and her preparation for her winning talk.

Published: June 3, 2024

The purpose of this study is to see if vorinostat is safe for people with moderate-to-severe CD and to see if it is safe for people with moderate-to-sever CD to receive maintenance therapy using Ustekinumab after successful treatment of Vorinostat.

Tell us about your role at NIAID and what a typical day at work looks like for you? My primary role is to lead my research team. We meet frequently to discuss experiments and projects. Sometimes I directly help with cell culture, microscopy, or other experiments. What is your favorite part of your job? What excites you most about coming to work? New data! Witnessing scientists in my team making a

Last Reviewed: March 1, 2024

How would you summarize what you currently do at NIAID? I am currently senior investigator and chief of the HIV Immunovirology Section in the Laboratory of Immunoregulation at NIAID. I direct and work with a small, but highly productive group of researchers and clinicians who 1) study the role of viral reservoirs in the pathogenesis of HIV disease; 2) examine host and viral factors that contribute

Last Reviewed: April 6, 2023

This presentation provides an overview of bacteria, what they are and how they are ubiquitous.

Last Reviewed: February 8, 2018

Lenette Lu, M.D., Ph.D., of the Massachusetts General Hospital K08 sample application

Last Reviewed: March 31, 2025

Joseph M. McCune, M.D., Ph.D., of the University of California, San Francisco R21 sample application

Last Reviewed: March 31, 2025

Generic Preclinical Development Plan for Human Monoclonal Antibodies

Last Reviewed: August 1, 2024

Last Reviewed: August 6, 2024

Sample application from Chengwen Li, Ph.D., and Richard Samulski, Ph.D., for NIH standard independent research project grant (R01).

Last Reviewed: November 29, 2022

This PDF provides a tool for evaluating organization review, coordinate and maintain oversight of all applications and proposal

Last Reviewed: November 26, 2019

This WORD document provides a tool for evaluating organization review, coordinate and maintain oversight of all applications and proposal

Last Reviewed: August 6, 2019

Office of Research on Women���s Health and NIH Support for Research on Women���s Health Report of the Advisory Committee on Research on Women���s Health: Fiscal Years 2019���2020 508-compliant PDF

Last Reviewed: March 8, 2022

Immunology Interest Group (IIG) Newsletter May

Last Reviewed: August 8, 2022

Immunologists at the NIH NIH Intramural Research Program manages a list of intramural immunologists. Immunology Interest Group Members The IIG committee has created an expanded the list of immunologists at NIH and included IIG member immunologists from the Food and Drug Administration (FDA). Members at the National Institutes of Health Members are listed by last name. Jump to the correct letter

Last Reviewed: March 10, 2025

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

This document proposes tests in vaccine trials to compare the vaccine and placebo groups in randomized vaccine trials.

Last Reviewed: August 6, 2019